Real-time enrollment status for this acute myeloid leukemia (aml) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:54 PM UTC
| NCT Number | NCT06811233 |
| Recruiting Status | Recruiting |
| Condition | Acute Myeloid Leukemia (AML) |
| Phase | Clinical Trial |
| Target Enrollment | 140 participants |
| Active Locations | 1 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | April 23, 2026 (Apr 23, 2026) |
As of July 13, 2026: Clinical trial NCT06811233 is currently recruiting participants. This clinical trial study for acute myeloid leukemia (aml) is actively seeking new participants at 1 location across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06811233 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06811233 was last updated Apr 23, 2026 (April 23, 2026). HelloStudys verifies this status automatically.